Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes.
Publication
, Journal Article
Holman, RR; Bethel, MA; Hernandez, AF
Published in: N Engl J Med
December 21, 2017
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
December 21, 2017
Volume
377
Issue
25
Start / End Page
2502
Location
United States
Related Subject Headings
- Venoms
- Peptides
- Hypoglycemic Agents
- Humans
- Glycated Hemoglobin
- General & Internal Medicine
- Exenatide
- Drug Administration Schedule
- Diabetes Mellitus, Type 2
- 42 Health sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Holman, R. R., Bethel, M. A., & Hernandez, A. F. (2017). Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med, 377(25), 2502. https://doi.org/10.1056/NEJMc1714163
Holman, Rury R., M Angelyn Bethel, and Adrian F. Hernandez. “Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes.” N Engl J Med 377, no. 25 (December 21, 2017): 2502. https://doi.org/10.1056/NEJMc1714163.
Holman RR, Bethel MA, Hernandez AF. Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2017 Dec 21;377(25):2502.
Holman, Rury R., et al. “Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes.” N Engl J Med, vol. 377, no. 25, Dec. 2017, p. 2502. Pubmed, doi:10.1056/NEJMc1714163.
Holman RR, Bethel MA, Hernandez AF. Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2017 Dec 21;377(25):2502.
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
December 21, 2017
Volume
377
Issue
25
Start / End Page
2502
Location
United States
Related Subject Headings
- Venoms
- Peptides
- Hypoglycemic Agents
- Humans
- Glycated Hemoglobin
- General & Internal Medicine
- Exenatide
- Drug Administration Schedule
- Diabetes Mellitus, Type 2
- 42 Health sciences